A clinical trial of MK-1824 in healthy participants (MK-1824-002)

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 40
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy adults to take MK-1824. The record lists heart failure with preserved ejection fraction as the condition studied.

Age

18 Years to 64 Years

Sex

All sexes can join.

This trial only enrols healthy participants. The registry sentence this rests on: A clinical trial of MK-1824 in healthy participants (MK-1824-002)

Read by machine on 9 Nov 2026.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details